The axial spondyloarthritis (axSpA) treatment market is estimated to be valued at USD 6.48 billion in 2025 and is expected to reach USD 10.89 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032. https://www.zupyak.com/p/4590182/t/axial-spondyloarthritis-axspa-treatment-market-is-estimated-to-witness-high-growth-owing-to-biologic-therapy-adoption